surfaceoncology – This #NationalCancerResearchMonth, we are joining the American Association for Cancer Research (AACR) and the oncology community to celebrate the advances in cancer research and recognize the potential to change patient outcomes. At Surface, we are proud of our progress in developing multiple antibody immunotherapy candidates and are committed to continuing to confront scientific challenges through our research.